Asia Spotlight: Improve Quality Or You're Out, Says China FDA Commissioner
Executive Summary
In a rare public speech, China FDA Commissioner Bi Jingquan calls for improved drug quality and an ecosystem to reward high-quality medicines, highlighting the agency’s drive to step up enforcement amid another recent scandal that has revealed broad quality problems.
You may also be interested in...
China Regulatory Shakeup: Top Regulator Out, Commissioner Reprimanded Amid Vaccine Scandal
Amid aftermath of latest vaccine scandal, top officials including China’s drug reform flagbearer are forced to resign, sending shock waves across the industry.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.